Chuck Royce's CLBT Position Overview
Chuck Royce (via Royce & Associates Lp) currently holds 90,048 shares of Cellebrite DI Ltd. (CLBT) worth $1.62 M, representing 0.02% of the portfolio. First purchased in 2022-Q4, this medium-term investment has been held for 13 quarters.
Based on 13F filings, Chuck Royce has maintained a strategic position in CLBT, demonstrating sustained confidence in this investment. Largest addition occurred in Q1 2023, adding 100,000 shares. Largest reduction occurred in Q4 2024, reducing 398,303 shares.
Analysis based on 13F filings available since 2013 Q2
Chuck Royce's Cellebrite DI (CLBT) Holding Value Over Time
Track share changes against reported price movement
Quarterly Cellebrite DI (CLBT) Trades by Chuck Royce
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2022 | +560,700 | New Buy | 560,700 | $4.36 |
| Q1 2023 | +100,000 | Add 17.83% | 660,700 | $6.09 |
| Q2 2023 | +100,000 | Add 15.14% | 760,700 | $7.20 |
| Q1 2024 | +34,268 | Add 4.50% | 794,968 | $11.08 |
| Q2 2024 | -84,481 | Reduce 10.63% | 710,487 | $11.95 |
| Q4 2024 | -398,303 | Reduce 56.06% | 312,184 | $22.03 |
| Q1 2025 | -130,000 | Reduce 41.64% | 182,184 | $19.43 |
| Q2 2025 | -152,291 | Reduce 83.59% | 29,893 | $16.00 |
| Q3 2025 | +64,049 | Add 214.26% | 93,942 | $18.53 |
| Q4 2025 | -3,894 | Reduce 4.15% | 90,048 | $18.03 |
Chuck Royce's Cellebrite DI Investment FAQs
Chuck Royce first purchased Cellebrite DI Ltd. (CLBT) in Q4 2022, acquiring 560,700 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Chuck Royce has held Cellebrite DI Ltd. (CLBT) for 13 quarters since Q4 2022.
Chuck Royce's largest addition to Cellebrite DI Ltd. (CLBT) was in Q4 2022, adding 560,700 shares worth $2.44 M.
According to the latest 13F filing for Q4 2025, Chuck Royce's firm, Royce & Associates Lp, owns 90,048 shares of Cellebrite DI Ltd. (CLBT), valued at approximately $1.62 M.
As of the Q4 2025 filing, Cellebrite DI Ltd. (CLBT) represents approximately 0.02% of Chuck Royce's publicly disclosed stock portfolio, making it one of their key holdings.
Chuck Royce's peak holding in Cellebrite DI Ltd. (CLBT) was 794,968 shares, as reported at the end of Q1 2024.